What is Semaglutide?
Semaglutide is the active ingredient behind Ozempic and Wegovy, and it plays a central role in both blood sugar regulation and weight management.
Ozempic and Wegovy for Naples patients:
Ozempic is used to manage blood sugar in patients with type 2 diabetes, while Wegovy, which is a higher-dose formulation of the same compound, is approved specifically for weight loss in patients who are overweight or obese.
Tirzepatide is the active ingredient in Mounjaro and Zepbound. It's a newer option built to address obesity directly, delivered as a weekly injection. In clinical trials, more than half of participants on higher doses lost over 20% of their body weight. This is a result that outpaces nearly every other non-surgical weight loss intervention available. For Naples patients dealing with the metabolic slowdown that comes with age, this level of effect can matter more than it would for a younger patient population.
Semaglutide vs. Tirzepatide in Naples: which is right for you?
Both medications help patients lose weight and, importantly, maintain that loss as long as treatment continues. Tirzepatide has generally produced stronger results at its highest dose, but the right choice depends on your health history, goals, and how your body responds. In studies, a 1mg weekly dose of Semaglutide combined with diet and exercise produced an average weight loss of up to 7% over a year, which is meaningfully ahead of placebo. At the higher 2.4mg weekly dose, average weight loss reached around 15%. Tirzepatide performed even more strongly in trials: over half of participants on the 15mg weekly dose lost more than 20% of their body weight! This is a result rivaled only by bariatric surgery.
Who qualifies for Semaglutide (Ozempic & Wegovy) and Tirzepatide (Zepbound & Mounjaro) treatments
The FDA has approved Ozempic, Wegovy, Zepbound, and Mounjaro for patients with a BMI of 30 or higher. Patients with a BMI of 27 or higher may also qualify if they have related conditions such as type 2 diabetes or hypertension: these are conditions that show up at higher rates in Naples' older population than in many other Florida markets.
How does Semaglutide and Tirzepatide work?
Both medications regulate insulin release, prompting the pancreas to respond appropriately when blood sugar rises. They also slow gastric emptying, which reduces appetite and supports sustainable weight loss over time.
How is treatment administered?
Treatment starts with a low weekly dose, which is gradually increased roughly every four weeks under a provider's supervision based on your response and tolerance.
What kind of plans do we offer for advanced weight loss at this Naples medical weight loss clinic?
Medication and supplies are shipped directly to the patient each month, with dosing adjustments and monitoring handled remotely by the care team based on ongoing check-ins and lab work. For many Naples patients, particularly those managing treatment around travel or a seasonal residence, this ends up being a more flexible fit than a traditional clinic visit model.
What is Retatrutide?
Retatrutide is a newer "triple hormone receptor agonist". It activates GLP-1, GIP, and glucagon receptors simultaneously, which produces broader effects on appetite, blood sugar, and metabolism than single- or dual-receptor medications. Naples patients interested in Retatrutide should speak with a provider directly to determine whether it's an appropriate option.
